ai drug design

METANOVA LABS is a crypto-native biotech company at the forefront of drug discovery. We are developing next generation therapeutics that regulate mental states and restore critical biological processes. 

Powered by the Bittensor network, our decentralized drug screening subnet harnesses global compute and collective intelligence to navigate huge unexplored chemical spaces, uncovering breakthrough compounds with unmatched efficiency. We are developing AI tools not just to accelerate our own R&D but to empower medical innovation by all.

reprogramming body + mind

We transcend disease‑centric medicine by focusing on the neurosignaling circuits that shape thought, emotion, and behavior. We’re on a mission to develop innovative small molecules that target systems associated with reward and learning mechanisms key in regulating focus, appetite, social connection, rest, sleep, and other foundational behaviors for lifelong health and wellbeing.

Our meta‑programming drugs operate at the source to foster lasting change. Our mission is to rewrite the rules of drug discovery by:

unlocking a deeper, more intelligent approach to healing and human potential

Traditional drug development is slow, expensive, and often siloed. We believe the future of medicine lies in open, incentive‑driven collaboration, where breakthroughs happen faster, cheaper, and in full view of the community. Our goal isn’t just to treat symptoms—it’s to optimize the underlying biological networks that define our health.

introducing

NOVA

global, decentralized engine for drug discovery

we are

accelerating medical innovation

with the power of market-driven global competition

JOIN US

  • Micaela Bazo

    CEO

    +

  • Pedro Penna, PhD

    CSO

    +

  • Amanda Casadei

    CTO

    +

  • Brayden Miller

    Engineer